SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)

Core Viewpoint - Purcell & Lefkowitz LLP is investigating Zenas BioPharma, Inc. to determine if the company's directors breached their fiduciary duties related to recent corporate actions [1]. Group 1: Investigation Details - The investigation is on behalf of Zenas BioPharma's shareholders [1]. - Shareholders interested in more information about their rights and options can contact Purcell & Lefkowitz LLP [2]. Group 2: Firm Background - Purcell & Lefkowitz LLP specializes in representing shareholders who are victims of securities fraud and breaches of fiduciary duty [3].